Novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, metabolites thereof, isomers thereof, enantiomers thereof or prodrugs thereof of Formula (I)
wherein the substituents are as defined herein, which are useful as therapeutic agents.
7-(substituted)piperazinyl-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acids, the pharmacologically acceptable salts thereof, compositions containing them, processes and intermediates for producing them, and methods of using them to treat bacterial infections in warm-blooded animals.
[EN] HETEROCYCLES AND USES THEREOF<br/>[FR] HÉTÉROCYCLES ET LEURS UTILISATIONS
申请人:[en]KUMQUAT BIOSCIENCES INC.
公开号:WO2022081912A2
公开(公告)日:2022-04-21
The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.